1 Min Read
May 3 (Reuters) - Eiger Biopharmaceuticals Inc
* Eiger announces U.S. IND filing of pegylated interferon lambda for hepatitis delta virus infection Source text for Eikon: Further company coverage: (Bangalore.firstname.lastname@example.org)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.